Capricor Therapeutics CAPR Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Capricor Therapeutics (CAPR) reported comprehensive income (loss), net of tax, attributable to parent of -$34.48M in Q1 2026.
- How has Capricor Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Capricor Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 46.1% year-over-year, from -$23.61M to -$34.48M.
- What is the long-term trend for Capricor Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Capricor Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 51.6% compound annual growth rate (CAGR), from -$20.02M to -$105.79M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a more holistic view of the company's financial performance by including gains and losses that bypass the traditional income statement. Investors use this to evaluate the total impact of market and economic conditions on the company's overall financial position.